Next Article in Journal
Measurable Residual Disease Analysis by Flow Cytometry: Assay Validation and Characterization of 385 Consecutive Cases of Acute Myeloid Leukemia
Next Article in Special Issue
Real-World Data on the Associations of Tricyclic Antidepressants and Selective Serotonin Reuptake Inhibitors with Gynecologic Cancer Risk
Previous Article in Journal
Measurable Residual Disease Testing During Treatment with Bispecific Antibodies for Lymphoma
Previous Article in Special Issue
Enhancing Progestin Therapy with a Glucagon-Like Peptide 1 Agonist for the Conservative Management of Endometrial Cancer
 
 
Article

Article Versions Notes

Cancers 2025, 17(7), 1154; https://doi.org/10.3390/cancers17071154
Action Date Notes Link
article html file updated 24 June 2025 22:17 CEST Update https://www.mdpi.com/2072-6694/17/7/1154/html
article html file updated 29 March 2025 09:12 CET Original file -
article supplementary file uploaded. 29 March 2025 09:11 CET - https://www.mdpi.com/2072-6694/17/7/1154#supplementary
article pdf uploaded. 29 March 2025 09:11 CET Version of Record https://www.mdpi.com/2072-6694/17/7/1154/pdf
article xml uploaded. 29 March 2025 09:11 CET Update https://www.mdpi.com/2072-6694/17/7/1154/xml
article xml file uploaded 29 March 2025 09:11 CET Original file -
Back to TopTop